Key Takeaways
- Oura has shelved its Nasdaq public listing plans indefinitely
- Market volatility and uncertainty drove the decision to delay
- The planned offering targeted up to $2.2 billion in proceeds
- The company’s revenue surged approximately 75% year-over-year with 5 million-plus subscribers
- This postponement mirrors recent moves by Holtec and Bamboo Insurance
The Finnish health technology company Oura has pulled back from its anticipated initial public offering on the Nasdaq. Market instability and uncertain conditions were cited as primary factors behind the withdrawal.
Originally, the smart ring manufacturer intended to set its share price on Tuesday with trading commencing the following day. However, the firm opted to halt the entire listing process.
“Our mission is to empower people to live healthier, longer, and an IPO is just one step in our journey,” stated Tom Hale, CEO of Oura. He emphasized the company possesses “the luxury of choosing our moment.”
The proposed deal involved 50 million shares with a price band of $40 to $44 per share. Had the offering priced at the upper limit, Oura stood to collect approximately $2.2 billion.
Such pricing would have established the firm’s fully diluted market capitalization at roughly $15.62 billion.
Market Headwinds Behind the Postponement
Multiple challenges are currently impacting the IPO landscape this season. Climbing treasury yields have prompted investors to scrutinize valuations of high-growth companies more carefully.
The Federal Reserve’s latest rate increase has intensified these pressures. Market participants are also debating the sustainability of artificial intelligence-driven market momentum.
Oura joins other companies stepping away from public offerings. Nuclear technology firm Holtec withdrew its IPO earlier this month, while Bamboo Insurance similarly postponed its market debut.
Industry observers indicated that investor appetite for Oura’s shares remained relatively healthy, with the book reportedly oversubscribed by approximately four times. Analysts characterized this reception as respectable though not exceptional for an established consumer technology brand.
Market focus is now turning toward artificial intelligence company Anthropic. Sources indicate it may pursue a public listing following November’s midterm elections, potentially ranking among the most significant IPOs in history.
Strong Financial Momentum
The IPO postponement comes despite impressive financial metrics. For the nine-month period concluding in June, Oura generated $1.2 billion in revenue, representing approximately 75% growth compared to the previous year.
During this timeframe, the company posted pretax profits of $107 million, excluding non-cash expenses. Oura projected revenue growth of 90% for fiscal year 2026 versus the prior fiscal period.
The company’s smart rings are priced between $400 and $500. Annual memberships cost $70, providing users with comprehensive health metrics including sleep analysis, body temperature monitoring, blood oxygen readings, and personalized recommendations through an AI-powered health assistant.
Subscription retention rates hover around 85%, according to the company. More than 70% of its user base consists of female subscribers.
Founded over ten years ago in Finland, Oura achieved a private market valuation of approximately $11 billion in last year’s funding round. The proposed IPO pricing represented an increase from that benchmark.
The firm highlighted strong market reception for its latest product, the Oura Ring 5, following its recent introduction. Total paying members across its platform have expanded to 5.7 million individuals.
Oura has not disclosed a revised schedule for resuming its public offering process.
Get 3 Free Stock Ebooks
Discover top-performing stocks in AI, Crypto, and Technology with expert analysis.
- Top 10 AI Stocks - Leading AI companies
- Top 10 Crypto Stocks - Blockchain leaders
- Top 10 Tech Stocks - Tech giants
